Howard K. Surks

2.6k total citations
32 papers, 1.8k citations indexed

About

Howard K. Surks is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Howard K. Surks has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Surgery. Recurrent topics in Howard K. Surks's work include Protein Kinase Regulation and GTPase Signaling (10 papers), Nitric Oxide and Endothelin Effects (8 papers) and Lipoproteins and Cardiovascular Health (5 papers). Howard K. Surks is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (10 papers), Nitric Oxide and Endothelin Effects (8 papers) and Lipoproteins and Cardiovascular Health (5 papers). Howard K. Surks collaborates with scholars based in United States, France and Japan. Howard K. Surks's co-authors include Michael E. Mendelsohn, Wendy Baur, Naoki Mochizuki, Kwong‐Yui Tang, S Georgescu, Thomas Lincoln, Masaaki Ito, Yasuyo Kasai, Richard H. Karas and Yuepeng Wang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Howard K. Surks

31 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard K. Surks United States 20 1.0k 421 408 207 197 32 1.8k
Roberta Roncarati Italy 20 1.3k 1.3× 547 1.3× 618 1.5× 192 0.9× 76 0.4× 30 2.3k
Iván P. Uray United States 20 1.3k 1.3× 404 1.0× 475 1.2× 129 0.6× 132 0.7× 40 2.3k
Angela Wirth Germany 15 856 0.8× 327 0.8× 285 0.7× 162 0.8× 114 0.6× 26 1.4k
M. Koji Owada Japan 21 857 0.8× 508 1.2× 302 0.7× 261 1.3× 145 0.7× 43 1.8k
Shawn C. Black United States 20 1.1k 1.0× 248 0.6× 417 1.0× 96 0.5× 162 0.8× 46 2.0k
Ping H. Wang United States 26 1.1k 1.1× 275 0.7× 525 1.3× 131 0.6× 261 1.3× 51 1.9k
Jingyi Gong United States 20 1.0k 1.0× 613 1.5× 443 1.1× 293 1.4× 122 0.6× 35 2.3k
Kotaro Numaguchi Japan 13 846 0.8× 258 0.6× 447 1.1× 137 0.7× 185 0.9× 22 1.5k
Denis Féliers United States 31 1.2k 1.2× 362 0.9× 213 0.5× 89 0.4× 232 1.2× 57 2.4k
Rüdiger von Harsdorf Germany 27 1.6k 1.6× 411 1.0× 613 1.5× 198 1.0× 111 0.6× 36 2.7k

Countries citing papers authored by Howard K. Surks

Since Specialization
Citations

This map shows the geographic impact of Howard K. Surks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard K. Surks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard K. Surks more than expected).

Fields of papers citing papers by Howard K. Surks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard K. Surks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard K. Surks. The network helps show where Howard K. Surks may publish in the future.

Co-authorship network of co-authors of Howard K. Surks

This figure shows the co-authorship network connecting the top 25 collaborators of Howard K. Surks. A scholar is included among the top collaborators of Howard K. Surks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard K. Surks. Howard K. Surks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Udelson, James E., Jan Bělohlávek, Andrej Dukát, et al.. (2025). Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure. JACC Heart Failure. 14(1). 102706–102706.
2.
Udelson, James E., Howard K. Surks, Jan Bělohlávek, et al.. (2024). A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure. European Heart Journal. 45(Supplement_1). 1 indexed citations
3.
Chow, Timothy Y., Pirouz Shamszad, Christopher Vinnard, et al.. (2023). First‐in‐human study with SAR445088: A novel selective classical complement pathway inhibitor. Clinical and Translational Science. 16(4). 673–685. 12 indexed citations
4.
Li, Zhaoyang, S Richards, Howard K. Surks, Alice K. Jacobs, & Michael Panzara. (2018). Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis. Clinical & Experimental Immunology. 194(3). 295–314. 56 indexed citations
5.
Wang, Guangrong, Howard K. Surks, Kwong‐Yui Tang, et al.. (2013). Steroid-sensitive Gene 1 Is a Novel Cyclic GMP-dependent Protein Kinase I Substrate in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 288(34). 24972–24983. 11 indexed citations
6.
Teramoto, Tamio, et al.. (2013). Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia. Atherosclerosis. 230(1). 52–60. 27 indexed citations
7.
Gutstein, David E., Rajesh Krishna, Douglas G. Johns, et al.. (2011). Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction. Clinical Pharmacology & Therapeutics. 91(1). 109–122. 47 indexed citations
8.
Zheng, Xiaoyu, Howard K. Surks, & Xin Zhang. (2010). Single cell contractility studies based on compact moiré system over periodic gratings. Applied Physics Letters. 96(21). 1 indexed citations
9.
Surks, Howard K., et al.. (2010). Little ROCK is a ROCK1 pseudogene expressed in human smooth muscle cells. BMC Genetics. 11(1). 22–22. 2 indexed citations
10.
Sharma, Alok, Guo‐Ping Zhou, Joseph Kupferman, et al.. (2008). Probing the Interaction between the Coiled Coil Leucine Zipper of cGMP-dependent Protein Kinase Iα and the C Terminus of the Myosin Binding Subunit of the Myosin Light Chain Phosphatase. Journal of Biological Chemistry. 283(47). 32860–32869. 58 indexed citations
11.
Kutcher, Matthew, Alexey Y. Kolyada, Howard K. Surks, & Ira M. Herman. (2007). Pericyte Rho GTPase Mediates Both Pericyte Contractile Phenotype and Capillary Endothelial Growth State. American Journal Of Pathology. 171(2). 693–701. 72 indexed citations
12.
Surks, Howard K., et al.. (2005). M-RIP Targets Myosin Phosphatase to Stress Fibers to Regulate Myosin Light Chain Phosphorylation in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 280(52). 42543–42551. 53 indexed citations
13.
Endo, Akira, Howard K. Surks, Seibu Mochizuki, Naoki Mochizuki, & Michael E. Mendelsohn. (2004). Identification and Characterization of Zipper-interacting Protein Kinase as the Unique Vascular Smooth Muscle Myosin Phosphatase-associated Kinase. Journal of Biological Chemistry. 279(40). 42055–42061. 42 indexed citations
14.
Lu, Qing, David C. Pallas, Howard K. Surks, et al.. (2004). Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proceedings of the National Academy of Sciences. 101(49). 17126–17131. 216 indexed citations
15.
Wang, Yuepeng, et al.. (2004). Formin Homology Domain Protein (FHOD1) Is a Cyclic GMP-dependent Protein Kinase I-binding Protein and Substrate in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 279(23). 24420–24426. 31 indexed citations
16.
Surks, Howard K., Christopher T. Richards, & Michael E. Mendelsohn. (2003). Myosin Phosphatase-Rho Interacting Protein. Journal of Biological Chemistry. 278(51). 51484–51493. 77 indexed citations
17.
Surks, Howard K. & Michael E. Mendelsohn. (2003). Dimerization of cGMP-dependent protein kinase 1α and the myosin-binding subunit of myosin phosphatase: role of leucine zipper domains. Cellular Signalling. 15(10). 937–944. 44 indexed citations
18.
Lu, Qing, Howard K. Surks, Wendy Baur, et al.. (2003). Regulation of Estrogen Receptor α-mediated Transcription by a Direct Interaction with Protein Phosphatase 2A. Journal of Biological Chemistry. 278(7). 4639–4645. 57 indexed citations
19.
Surks, Howard K., et al.. (1999). Transient Myocardial Dysfunction Associated with Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema: Recognition by Serial Echocardiographic Studies. Journal of the American Society of Echocardiography. 12(12). 1107–1109. 3 indexed citations
20.
Salomon, Robert, et al.. (1998). A Case of giant cell myocarditis and malignant thymoma: A postmortem diagnosis by needle biopsy. Clinical Cardiology. 21(1). 48–51. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Roncarati Breakdown of academic impact, for papers by Iván P. Uray Breakdown of academic impact, for papers by Angela Wirth Breakdown of academic impact, for papers by M. Koji Owada Breakdown of academic impact, for papers by Shawn C. Black Breakdown of academic impact, for papers by Ping H. Wang Breakdown of academic impact, for papers by Jingyi Gong Breakdown of academic impact, for papers by Kotaro Numaguchi Breakdown of academic impact, for papers by Denis Féliers Breakdown of academic impact, for papers by Rüdiger von Harsdorf
Rankless by CCL
2026